Advertisement

Topics

Latest "Myelos Corporation" News Stories

08:29 EDT 21st October 2017 | BioPortfolio

Here are the most relevant search results for "Myelos Corporation" found in our extensive news archives from over 250 global news sources.

More Information about Myelos Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Myelos Corporation for you to read. Along with our medical data and news we also list Myelos Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Myelos Corporation Companies for you to search.

Showing "Myelos Corporation" News Articles 1–25 of 282

Relevant

Savaria Announces Resignation of Director and Appointment of New Director

LAVAL, QUEBEC -- (Marketwired) -- 07/07/17 -- Savaria Corporation (TSX: SIS) ("Savaria" or the "Corporation"), one of North America's leaders in the accessibility industry, is pleased to announce the appointment of Sebastien Bourassa to the Board of Directors of the Corporation, effective immediately. Mr. Bourassa, who currently holds the position of Operation & Integration Vice President w...


Ventripoint Announces Results of Annual Shareholders' Meeting and Grant of Options and DSUs

TORONTO, ONTARIO -- (Marketwired) -- 08/16/17 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSX VENTURE: VPT) announces that at its Annual General Meeting on August 14, 2017 the shareholders re-elected Dr. George Adams, Mr. Danny Dalla-Longa, Dr. Alan Rabinowitz, Dr. Don Segal and Mr. David Willis as Directors of the Corporation. They further approved the Incentive Stock ...

Mitsubishi Tanabe Pharma Corporation Completes Acquisition of NeuroDerm

REHOVOT, Israel, Oct. 18, 2017 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, announced today the completion of the previously announced acquisition of NeuroDerm by Mitsubishi Tanabe Pharma Corporation (TSE Code: 4508), a publicly traded company on the Tokyo Stock Exchang...


ICC International Cannabis Corporation Provides Cannabinoid Extract Business Segment Update

Highlights:

NeuroDerm Shareholders Approve Proposed Acquisition by Mitsubishi Tanabe Pharma Corporation

REHOVOT, Israel, Sept. 12, 2017 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, announced that at NeuroDerm’s extraordinary general meeting of shareholders held today, NeuroDerm shareholders voted to approve the previously announced acquisition by Mitsubishi Tanabe Pharm...

International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson's Disease

CARLSBAD, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today reported that two more patients with Parkinson’s disease were successfully transplanted with ISCO’s proprietary ISC-hpNSC® cells at the Royal Melbourne Hospital (R...

Advanced Proteome Therapeutics Corporation Completes Rights Offering for Gross Proceeds of Approximately $430,000

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/11/17 -- Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC)(FRANKFURT: 0E8) is pleased to report that it has completed its previously announced rights offering (the "Rights Offering"). Under the Rights Offering, on July 10, 2017, 7,136,216 units of the Corporation (the "Units") were distributed at a price of ...

International Stem Cell Corporation to Move Forward with Traumatic Brain Injury Phase II Clinical Trial

CARLSBAD, Calif., Sept. 20, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the completion of its preclinical studies in Traumatic Brain Injury (TBI) program will po...

International Stem Cell Corporation to Expand its Revenue Generating Biomedical Businesses to Support Ongoing and Future Clinical Trials

H1 2017 operating income from ISCO’s revenue generating subsidiaries demonstrated an increase of 51% compared to its income in H1 2016, while H1 2017 revenue was $3.8 million. Edison Investment Research target price for ISCO shares is $6.62 per share* CARLSBAD, Calif., Sept. 26, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO)  (www.internationalstemcell.com) ("...

UNITED THERAPEUTICS CORPORATION (UTHR) INVESTOR ALERT: Legal Investigation for Potential ...

Girard Gibbs LLPEileen Epstein, 510-350-9728EJE@CLASSLAWGROUP.COM Read more...

Probably Relevant

Hydropothecary Announces Stock Option Grants to Officers and Employees

GATINEAU, QC--(Marketwired - September 08, 2017) - The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE: THCX) announces that it has made a grant of stock options under its stock option plan to certain of its officers to acquire a total of 650,000 common shares of the Company. In addition, the Company has granted options to acquire an aggregate of 1,000 common shares of the Compan...

Advantis Corp. Connects At Industry Outreach Event

NEWPORT BEACH, CA--(Marketwired - Jun 26, 2017) - ADVANTIS CORPORATION ( OTC PINK : ADVT) CEO, Christopher Swartz, attended the Coastal Pacific political Read more...

Industry Leader, Darren Cherry, Leads Advantis Corp. Into the Future

NEWPORT BEACH, CA--(Marketwired - Sep 19, 2017) - ADVANTIS CORPORATION ( OTC PINK : ADVT) announced that it has agreed with leading wholesale, Read more...

BioElectronics Wins the Orthopedics This Week 2017 Sports Medicine Technology Award

FREDERICK, MD -- (Marketwired) -- 08/02/17 -- (OTC PINK: BIEL) BioElectronics Corporation's ActiPatch®, The New Technology for Pain Relief medical device, has won the Orthopedics This Week Sports Medicine Technology Award. Orthopedics This Week is the most widely read publication by clinicians, nurses, scientists, and others in the orthopedics industry. The panel of judges consisted of experien...

Advantis Corp. Setting Up Multi-State Amster-Can Canning Solutions

NEWPORT BEACH, CA--(Marketwired - Aug 21, 2017) - ADVANTIS CORPORATION ( OTC PINK : ADVT) is finalizing agreements with client partners in Oregon Read more...

BioElectronics Announces Update on Migraine Clinical Study Migraine Prevention Using ActiPatch (Neuromodulation Therapy)

FREDERICK, MD -- (Marketwired) -- 08/08/17 -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to report on the progress of its Migraine prevention clinical study. The randomized, double-blinded, sham-controlled study involving 48 subjects is designed to investigate if ActiPatch therapy can be used to prevent the frequency and intensity of migraine attacks. Since receiving...

Advantis Corp. Taking Delivery of More Efficient Amstercan Canning Machine, May Add Mobile ...

NEWPORT BEACH, CA--(Marketwired - Jun 28, 2017) - ADVANTIS CORPORATION ( OTC PINK : ADVT) is scheduled to receive the custom made canning Read more...

BioElectronics Announces Health Economics Study

FREDERICK, MD -- (Marketwired) -- 06/29/17 -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce the completion of a health economics study using its nonprescription drug-free ActiPatch® Musculoskeletal Pain Therapy for chronic pain. The goal was to investigate how using ActiPatch as a pain therapy would affect overall healthcare costs in the UK. The study invo...

BioElectronics Engages Keith Nalepka As Vice President of Sales and Marketing

FREDERICK, MD -- (Marketwired) -- 08/22/17 -- BioElectronics Corporation (OTC PINK: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has engaged Keith Nalepka as the Vice President of Sales and Marketing. Keith has over 15 years of experience working in the retail sales industry, both with large multi-million dollar brands and startups. He has a thor...

International Business Machines Corp - Doc re 10-Q

Company INTERNATIONAL BUSINESS MACHINES CORPORATION TIDM IBM Headline Notification of filing of document The Corporation's quarterly report on Form 10-Q date 25/07/2017 was filed with the United S...

International Business Machines Corp - Doc re Form 8-K

Company INTERNATIONAL BUSINESS MACHINES CORPORATION TIDM IBM Headline Notification of filing of document The Corporation's current report on Form 8-K dated October 17, 2017 was filed with the Unit...

BioElectronics to Present at 2017 UK Community Pharmacists' Meeting

FREDERICK, MD -- (Marketwired) -- 06/30/17 -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, is pleased to announce that Sree Koneru, Ph. D., VP of Product Development, will speak about the new science and technology behind chronic pain relief at the 2017 UK Pharmacy Forward Annual Conference. This meeting brings together independent and small-chain pharmacists for a one-day event...

Canadian Innovation: Hydropothecary Corporation set to release Canada's first-ever medical cannabis mouth spray

GATINEAU, QC--(Marketwired - July 25, 2017) - The Hydropothecary Corporation (TSX VENTURE: THCX) today announced it will soon launch Elixir No. 1 Canada's only legal medical marijuana sublingual (under tongue) mist. This new product, in a natural peppermint oil base and is approved for production and sale under the ACMPR by Health Canada, will begin shipping on July 31, 2017. Packaged in a chil...

Hydropothecary Receives Expanded Cannabis Storage Licence

GATINEAU, QC--(Marketwired - October 17, 2017) - The Hydropothecary Corporation (TSX VENTURE: THCX) ("THCX" or the "Company") is pleased to announce that Health Canada has granted a licence amendment more than doubling its current licensed storage capacity. The Company's current licensed capacity has been increased from 4,380 kg to 9,380 kg. The Company is also planning to construct additional va...

Acasti Pharma Grants Stock Options

LAVAL, QUEBEC -- (Marketwired) -- 06/14/17 -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ: ACST)(TSX VENTURE: ACST), today announced the grant of an aggregate of 1,021,500 stock options to its employees, executives and members of the Board of Directors under the Corporation's Stock Option Plan. Subject to the terms and conditions of the plan, these options will vest in equal annua...


Quick Search
Advertisement
 

News Quicklinks